Original Research Online Publishing Date: | ||||||||||||||||||||||||||||||
The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers Ali Salih Baay.
|
How to Cite this Article |
Pubmed Style Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol. 2017; 7(6): 628-633. doi:10.5455/njppp.2017.7.01235023012017 Web Style Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. https://www.njppp.com/?mno=253089 [Access: March 14, 2024]. doi:10.5455/njppp.2017.7.01235023012017 AMA (American Medical Association) Style Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol. 2017; 7(6): 628-633. doi:10.5455/njppp.2017.7.01235023012017 Vancouver/ICMJE Style Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol. (2017), [cited March 14, 2024]; 7(6): 628-633. doi:10.5455/njppp.2017.7.01235023012017 Harvard Style Ali Salih Baay (2017) The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol, 7 (6), 628-633. doi:10.5455/njppp.2017.7.01235023012017 Turabian Style Ali Salih Baay. 2017. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. National Journal of Physiology, Pharmacy and Pharmacology, 7 (6), 628-633. doi:10.5455/njppp.2017.7.01235023012017 Chicago Style Ali Salih Baay. "The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 628-633. doi:10.5455/njppp.2017.7.01235023012017 MLA (The Modern Language Association) Style Ali Salih Baay. "The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers." National Journal of Physiology, Pharmacy and Pharmacology 7.6 (2017), 628-633. Print. doi:10.5455/njppp.2017.7.01235023012017 APA (American Psychological Association) Style Ali Salih Baay (2017) The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. National Journal of Physiology, Pharmacy and Pharmacology, 7 (6), 628-633. doi:10.5455/njppp.2017.7.01235023012017 |